Diabetes management in an Australian primary care population

Journal of Clinical Pharmacy and Therapeutics

Volumn 36, Issue 6, 2011, Pages 664-672

  Krass, Ines ^a   Hebing, R ^b   Mitchell, B ^a   Hughes, J ^c   Peterson, G ^d   Song, Y J C ^a   Stewart, K ^e   Armour, C L ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UTRECHT UNIVERSITY   (Netherlands)

^c CURTIN UNIVERSITY   (Australia)

^d UNIVERSITY OF TASMANIA   (Australia)

^e MONASH UNIVERSITY   (Australia)

Author keywords

management; pharmacotherapy; primary care; therapy; type 2 diabetes mellitus

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; FIBRIC ACID DERIVATIVE; GLITAZONE DERIVATIVE; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA DERIVATIVE; THIAZIDE DIURETIC AGENT;

ADULT; AGED; ARTICLE; AUSTRALIA; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; BODY HEIGHT; BODY WEIGHT; DEMOGRAPHY; DIABETES EDUCATION; FEMALE; GLYCEMIC CONTROL; HUMAN; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL ACTIVITY; PRIMARY MEDICAL CARE; RETROSPECTIVE STUDY; SMOKING;

AGED; ANTIHYPERTENSIVE AGENTS; AUSTRALIA; BLOOD GLUCOSE; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 2; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; HYPOLIPIDEMIC AGENTS; LIPIDS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRIMARY HEALTH CARE; RETROSPECTIVE STUDIES;

EID: 80055036013     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2010.01221.x     Document Type: Article

References (33)

1. Roumen C, Blaak EE, Corpeleijn E, (2009) Lifestyle intervention for prevention of diabetes: determinants of success for future implementation. Nutrition Reviews, 67, 132-146.
2. World Health Organisation (2009) Diabetes. In: Diabetes. Fact Sheet Number 312. Available at: (accessed 20 January 2011).
3. Langford MC, (2004) Type 2 diabetes and chronic systolic heart failure: clinical implications. Journal of Cardiovascular Nursing, 19, S35-S44. quiz S45-S46.
4. UK Prospective Diabetes Study Group (1998) Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ, 317, 703-713.
5. Harris M, (2008) Challenges in diabetes management. Australian Family Physician, 37, 716-720.
6. Colagiuri S, Colagiuri R, Conway B, Grainger D, Davey P, (2003) DiabCost Australia: Asessing the Burden of Type 2 Diabetes in Australia. The Australian Centre for Diabetes Strategies; Diabetes Australia; M TAG and Eli Lilly Australia April, 2010. Available at:.
7. Del Prato S,. (2009) Megatrials in type 2 diabetes. From excitement to frustration? Diabetologia, 52, 1219-1226.
8. Monte SV, Slazak EM, Albanese NP, et al. (2009) Clinical and economic impact of a diabetes clinical pharmacy service program in a university and primary care-based collaboration model. Journal of the American Pharmacists Association: JAPhA, 49, 200-208.
9. Hakkennes S, Dodd K, (2008) Guideline implementation in allied health professions: a systematic review of the literature. Quality & Safety in Health Care, 17, 296-300.
10. Johnson CL, Nicholas A, Divine H, et al. (2008) Outcomes from DiabetesCARE: a pharmacist-provided diabetes management service. Journal of the American Pharmacists Association: JAPhA, 48, 722-730.
11. Krass I, Taylor SJ, Smith C, Armour CL, (2005) Impact on medication use and adherence of Australian pharmacists' diabetes care services. Journal of the American Pharmacists Association: JAPhA, 45, 33-40. (Pubitemid 46037318)
12. Resnick HE, Foster GL, Bardsley J, Ratner RE, (2006) Achievement of American Diabetes Association clinical practice recommendations among U.S. adults with diabetes, 1999-2002: the National Health and Nutrition Examination Survey. Diabetes Care, 29, 531-537. (Pubitemid 44115349)
13. Grant RW, Wexler DJ, Watson AJ, et al. (2007) How doctors choose medications to treat type 2 diabetes-a national survey of specialists and academic generalists. Diabetes Care, 30, 1448-1453. (Pubitemid 46871153)
14. Grimshaw JM, Thomas RE, MacLennan G, et al. (2004) Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technology Assessment (Winchester, England), 8, iii-iv.
15. Kemp TM, Barr EL, Zimmet PZ, et al. (2005) Glucose, lipid, and blood pressure control in Australian adults with type 2 diabetes: the 1999-2000 AusDiab. Diabetes Care, 28, 1490-1492. (Pubitemid 40756720)
16. NADC (2007) Final report, 2006, Australian National Diabetes Information Audit & Benchmarking. In:, Wah Cheung N., ed. Final report, 2006, Australian National Diabetes Information Audit & Benchmarking: Department of Health and Aging. Canberra: National Association of Diabetes Centres, 29. Available at:. (accessed 20 January 2011).
17. Bryant W, Greenfield JR, Chisholm DJ, Campbell LV, (2006) Diabetes guidelines: easier to preach than to practise? Medical Journal of Australia, 185, 305-309.
18. Mehuys E, De Bolle L, Van Bortel L, et al. (2008) Medication use and disease management of type 2 diabetes in Belgium. Pharmacy World & Science, 30, 51-56. (Pubitemid 350172647)
19. Anonymous. The Diabetes Pilot Program: Diabetes Medication Assistance Service In: The Diabetes Pilot Program: Diabetes Medication Assistance Service The Pharmacy Guild of Australia. Available at: (accessed 20 January 2011).
20. Halpern MT, Khan ZM, Schmier JK, et al. (2006) Recommendations for evaluating compliance and persistence with hypertension therapy using retrospective data. Hypertension, 47, 1039-1048. (Pubitemid 44289157)
21. Boden Institute of Obesity Nutrition and Exercise (2009). In:, Colagiuri S, Dickinson S, Girgis S, Colagiuri R,. eds. National evidence based guideline for blood glucose control in type 2 diabetes. Diabetes Australia and the NHMRC, Canberra.
22. Australian Centre for Diabetes Strategies (2004) National Evidence Based Guidelines for the Management of Type 2 Diabetes Mellitus. In:, Colgiuri S, Colagiuri R,. eds. National evidence based guidelines for the management of type 2 diabetes mellitus. Diabetes Australia Guideline Development Consortium.
23. Australian Centre for Diabetes Strategies (2009) National Evidence Based Guidelines for the Management of Type 2 Diabetes Mellitus. In:, Colagiuri S, Dickinson S, Girgis S, Colagiuri R,. eds. National evidence based guidelines for the management of type 2 diabetes mellitus. Diabetes Australia Guideline Development Consortium, Sydney.
24. Australian Centre for Diabetes Strategies (2004) National Evidence Based guidelines for type 2 diabetes mellitus. In:, Colagiuri S, Colagiuri R,. eds. National evidence based guidelines for type 2 diabetes mellitus. Diabetes Australia Guideline Development Consortium, Sydney.
25. American Diabetes Association (2010) Executive summary: standards of medical care in diabetes - 2010. Diabetes Care, 33 (Suppl. 1), S4-S10.
26. Thomas MC, Nestel PJ, (2007) Management of dyslipidaemia in patients with type 2 diabetes in Australian primary care. Medical Journal of Australia, 186, 128-130. (Pubitemid 46322365)
27. Agarwal G, Nair K, Cosby J, et al. (2008) GPs' approach to insulin prescribing in older patients: a qualitative study. British Journal of General Practice, 58, 569-575.
28. Hermansen K, Mortensen LS, Hermansen ML, (2008) Combining insulins with oral antidiabetic agents: effect on hyperglycemic control, markers of cardiovascular risk and disease. Vascular Health & Risk Management, 4, 561-574. (Pubitemid 352037916)
29. Wallace TM, Matthews DR, (2000) Poor glycaemic control in type 2 diabetes: a conspiracy of disease, suboptimal therapy and attitude. QJM, 93, 369-374. (Pubitemid 30386809)
30. Kidney Health Australia (2009) Fast facts on CKD in Australia. Kidney Health Australia. Available at: (accessed 20 January 2011).
31. Cramer JA, (2004) A systematic review of adherence with medications for diabetes. Diabetes Care, 27, 1218-1224. (Pubitemid 38579798)
32. Haupt D, Weitoft GR, Nilsson JL, (2009) Refill adherence to oral antihyperglycaemic drugs in Sweden. Acta Diabetologica, 46, 203-208.
33. Cooke CE, Fatodu H, (2006) Physician conformity and patient adherence to ACE inhibitors and ARBs in patients with diabetes, with and without renal disease and hypertension, in a medicaid managed care organization. Journal of Managed Care Pharmacy, 12, 649-655. (Pubitemid 47400561)